CAAS Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

CAAS Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,900	Closed	-$200K	–	1028
2022 Q4	$200K	Hold	19,900	–	–	0.01%	616
2022 Q3	$197K	Hold	19,900	–	–	0.01%	658
2022 Q2	$195K	Buy	+19,900	New	+$195K	0.01%	690

CAAS Capital Management's MSAC Position: Q1 2023 in Review

CAAS Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 19,900 shares — an estimated $200K sold.

CAAS Capital Management first reported a position in MSAC in Q2 2022 and held it in 3 quarters. The position peaked at $200K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

CAAS Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
CAAS Capital Management sold 19,900 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $200K.
CAAS Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2022 and held it in 3 quarters.
CAAS Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $200K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on CAAS Capital Management's 13F filing for Q1 2023, filed 15 May 2023.